☆ 4.4 Article

Are patients with rheumatologic diseases on chronic immunosuppressive therapy at lower risk of developing severe symptoms when infected with COVID-19?

CLINICAL RHEUMATOLOGY (2020)

Get Full Text
Add to Collection

Journal

CLINICAL RHEUMATOLOGY
Volume 39, Issue 7, Pages 2067-2068

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s10067-020-05184-3

Keywords

Chronic immunosuppressive therapy; COVID-19 disease severity; Rheumatologic disease

Categories

Rheumatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.